English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

The incidence of side effects following administration of mésoridazine and placebo was studied in a neurotic outpatient population using an open questionnaire and a symptom check-list. Men on mésoridazine reported more side effects with a symptom check-list than on the questionnaire. This difference was not significant in women. More symptoms were elicited with a check-list while the patients were on the drug than by questioning. These side effects were mainly gastro-intestinal and were mild. Cardio-vascular symptoms were as frequent on placebo as on the active drug. After six weeks of double-blind administration there was no difference in the total number of side effects reported for placebo and for mésoridazine.

Evaluation Des Effets Secondaires Chez Les Nevrotiques - Un Essai Avec La Mesoridazine: Et Le Placebo